Obstructive sleep apnea and hypertension: Mechanisms, evaluation, and management

Current Hypertension Reports

Volumn 9, Issue 6, 2007, Pages 529-534

  Dopp, John M ^a   Reichmuth, Kevin J ^a   Morgan, Barbara J ^a  

^a Department of Orthopedics and Rehabilitation ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ALDOSTERONE; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1;

ADRENERGIC ACTIVITY; BLOOD PRESSURE REGULATION; BREATHING PATTERN; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; INFLAMMATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIMARY HYPERALDOSTERONISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK REDUCTION; SCREENING TEST; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; DIASTOLE; HUMANS; HYPERTENSION; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SYSTOLE;

EID: 38049112837     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-007-0095-2     Document Type: Review

References (55)

1. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
2. Peppard PE, Young T, Palta M, et al.: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
3. Fletcher EC: Invited review: physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 2001, 90:1600-1605.
4. Becker HF, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68-73.
5. Narkiewicz K, van de Borne PJ, Montano N, et al.: Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998, 97:943-945.
6. Prabhakar NR, Peng YJ, Jacono FJ, et al.: Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 2005, 32:447-449.
7. Lam SY, Fung ML, Leung PS: Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body. J Appl Physiol 2004, 96:809-813.
8. Moller DS, Lind P, Strunge B, et al.: Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003, 16:274-280.
9. Peng YJ, Overholt JL, Kline D, et al.: Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci U S A 2003, 100:10073-10078.
10. Chen J, He L, Dinger B, et al.: Role of endothelin and endothelin A-type receptor in adaptation of the carotid body to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2002, 282:L1314-L1323.
11. Grimpen F, Kanne P, Schulz E, et al.: Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 2000, 15:320-325.
12. Gjorup PH, Sadauskiene L, Wessels J, et al.: Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007, 20:44-52.
13. Sun SY, Wang W, Zucker IH, et al.: Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 1999, 86:1273-1282.
14. Weiss JW, Liu MD, Huang J: Sleep apnoea and hypertension: physiological bases for a causal relation: physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp Physiol 2007, 92:21-26.
15. Zimmerman MC, Lazartigues E, Lang JA, et al.: Superoxide mediates the actions of augiotensin II in the central nervous system. Circ Res 2002, 91:1038-1045.
16. Zucker IH: Brain angiotensin II: new insights into its role in sympathetic regulation. Circ Res 2002, 90:503-505.
17. Huang J, Tamisier R, Ji E, et al.: Chronic intermittent hypoxia modulates nNOS mRNA and protein expression in the rat hypothalamus. Respir Physiol Neurobiol 2007, 158:30-38.
18. Phillips SA, Olson EB, Morgan BJ, et al.: Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 2004, 286:H388-H393.
19. El Solh AA, Saliba R, Bosinski T, et al.: Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006, 27:997-1002.
20. Grebe M, Eisele HJ, Weissmann N, et al.: Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006, 173:897-901.
21. Lattimore JL, Wilcox I, Skilton M, et al.: Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006, 61:491-495.
22. Ip MS, Lam B, Chan LY, et al.: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000, 162:2166-2171.
23. Schulz R, Mahmoudi S, Hattar K, et al.: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000, 162:566-570.
24. Wolk R, Svatikova A, Otto ME, et al.: Plasma adrenomedullin and obstructive sleep apnea. Am J Hypertens 2004, 17:74-76.
25. Schulz R, Flototto C, Jahn A, et al.: Circulating adrenomedullin in obstructive sleep apnoea. J Sleep Res 2006, 15:89-95.
26. Yamamoto H, Teramoto S, Yamaguchi Y, et al.: Long-term oxygen administration reduces plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome. Sleep Med 2007, In press.
27. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al.: Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007, 131:453-459.
28. Tanriverdi H, Evrengul H, Kara CO, et al.: Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 2006, 73:741-750.
29. Phillips C, Hedner J, Berend N, et al.: Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 2005, 28:604-609.
30. Drager LF, Bortolotto LA, Figueiredo AC, et al.: Obstructive sleep apuea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007, 131:1379-1386.
31. Yokoe T, Minoguchi K, Matsuo H, et al.: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107:1129-1134.
32. Gonzalez NC, Allen J, Schmidt EJ, et al.: Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am J Physiol Heart Circ Physiol 2007, 292:H2285-H2294.
33. Zhao Q, Ishibashi M, Hiasa K, et al.: Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 2004, 44:264-270.
34. Allahdadi KJ, Walker BR, Kanagy NL: Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005, 45:705-709.
35. Palma BD, Gabriel A Jr, Bignotto M, et al.: Paradoxical sleep deprivation increases plasma endothelin levels. Braz J Med Biol Res 2002, 35:75-79.
36. Zhang J, Zhao B, Gesongluobu, et al.: Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea. Hypertens Res 2000, 23:407-411.
37. Bostrom KB, Hedner J, Melander O, et al.: Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 2007, 25:779-783.
38. Patel SR, Emma KL, Mignot E, et al.: The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep 2007, 30:531-533.
39. Sjostrom C, Lindberg E, Elmasry A, et al.: Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 2002, 57:602-607.
40. Netzer NC, Stoohs RA, Netzer CM, et al.: Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999, 131:485-491.
41. Calhoun DA, Nishizaka MK, Zaman MA, et al.: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002, 40:892-896.
42. Amin RS, Carroll JL, Jeffries JL, et al.: Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 2004, 169:950-956.
43. Leung LC, Ng DK, Lau MW, et al.: Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome. Chest 2006, 130:1009-1017.
44. Zintzaras E, Kaditis AG: Sleep-disordered breathing and blood pressure in children: a meta-analysis. Arch Pediatr Adolesc Med 2007, 161:172-178.
45. Heitmann J, Ehlenz K, Penzel T, et al.: Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004, 23:255-262.
46. Norman D, Loredo JS, Nelesen RA, et al.: Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006, 47:840-845.
47. Robinson GV, Smith DM, Langford BA, et al.: Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006, 27:1229-1235.
48. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al.: Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006, 129:1459-1467.
49. Alajmi M, Mulgrew AT, Fox J, et al.: Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185:67-72.
50. Bazzano LA, Khan Z, Reynolds K, et al.: Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
51. Haentjens P, Van Meerhaeghe A, Moscariello A, et al.: The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167:757-764.
52. Martinez-Garcia MA, Gomez-Aldaravi R, Soler-Cataluna JJ, et al.: Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007, 29:951-957.
53. Morgan BJ, Dempsey JA, Pegelow DF, et al.: Blood pressure perturbations caused by subclinical sleep-disordered breathing. Sleep 1998, 21:737-746.
54. Marin JM, Carrizo SJ, Vicente E, et al.: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
55. Gotsopoulos H, Kelly JJ, Cistulli PA: Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep 2004, 27:934-941.